US Patent Issued to The Research Foundation for The State University of New York, KDx Diagnostics on July 22 for "Keratin 17 as a biomarker for bladder cancer" (New York, California Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,366,574, issued on July 22, was assigned to The Research Foundation for The State University of New York (Albany, N.Y.) and KDx Diagnostics Inc. (Cambell, Calif.).

"Keratin 17 as a biomarker for bladder cancer" was invented by Kenneth R. Shroyer (Setauket, N.Y.), Luisa F. Escobar-Hoyos (New York) and Nam Kim (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current disclosure provides methods for detecting and analyzing K17 expression in a bladder sample obtained from a subject. The current disclosure also pertains to methods and kits for identifying a mammalian subject with bladder cancer by detecting the expression of K17 in a sampl...